• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
76,264.33 736.38
( 0.97%)
Global Indices
Nasdaq
51,233.54 363.79
(0.72%)
Dow Jones
7,453.14 37.84
(0.51%)
Hang Seng
69,318.21 3,298.17
(5.00%)
Nikkei 225
10,460.24 156.36
(1.52%)
Forex
USD-INR
95.49 0.16
(0.17%)
EUR-INR
110.25 0.17
(0.15%)
GBP-INR
127.74 0.15
(0.12%)
JPY-INR
0.60 0.00
(0.21%)

EQUITY - MARKET SCREENER

Sreechem Resins Ltd
Industry :  Chemicals
BSE Code
ISIN Demat
Book Value()
514248
INE377C01010
33.4761905
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
0
14.3
EPS(TTM)
Face Value()
Div & Yield %
0
10
0
 

Lincoln Pharmaceuticals consolidated net profit rises 0.43% in the March 2026 quarter
May 29,2026
Net profit of Lincoln Pharmaceuticals rose 0.43% to Rs 11.63 crore in the quarter ended March 2026 as against Rs 11.58 crore during the previous quarter ended March 2025. Sales rose 11.36% to Rs 187.28 crore in the quarter ended March 2026 as against Rs 168.18 crore during the previous quarter ended March 2025.

For the full year,net profit rose 6.73% to Rs 87.89 crore in the year ended March 2026 as against Rs 82.35 crore during the previous year ended March 2025. Sales rose 7.67% to Rs 671.03 crore in the year ended March 2026 as against Rs 623.23 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales187.28168.18 11 671.03623.23 8
OPM %13.2715.89 -14.5616.28 -
PBDT20.3919.47 5 130.12122.09 7
PBT16.7016.25 3 115.63109.19 6
NP11.6311.58 0 87.8982.35 7